about
Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein geneAntigenicity of rabies virus glycoproteinAn mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn PigsNeutralization of reovirus: the gene responsible for the neutralization antigenRabies Control and Treatment: From Prophylaxis to Strategies with Curative PotentialCharacterization of intramolecular disulfide bonds and secondary modifications of the glycoprotein from viral hemorrhagic septicemia virus, a fish rhabdovirus.The adaptation of a CTN-1 rabies virus strain to high-titered growth in chick embryo cells for vaccine development.Chimeric lyssavirus glycoproteins with increased immunological potentialA permanent host shift of rabies virus from Chiroptera to Carnivora associated with recombination.Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicityRescue of rabies virus from cloned cDNA and identification of the pathogenicity-related gene: glycoprotein gene is associated with virulence for adult mice.Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine.Raccoon poxvirus recombinants expressing the rabies virus nucleoprotein protect mice against lethal rabies virus infectionSequencing and molecular characterization of CTNCEC25, a China fixed rabies virus vaccine strain CTN-1 adapted to primary chicken embryo cells.Rabies virus glycoprotein. II. Biological and serological characterization.Structure-function relationships and mode of replication of animal rhabdoviruses.A new competitive enzyme-linked immunosorbent assay demonstrates adequate immune levels to rabies virus in compulsorily vaccinated Japanese domestic dogsWalking along the rabies genome: is the large G-L intergenic region a remnant gene?A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infectionViral hemorrhagic septicemia of rainbow trout: relation between the G polypeptide and antibody production in protection of the fish after infection with the F25 attenuated variant.Rabies group-specific ribonucleoprotein antigen and a test system for grouping and typing of rhabdoviruses.A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein.Rhabdovirus replication in enucleated host cells.Rabies virus glycoprotein is an important determinant for the induction of innate immune responses and the pathogenic mechanisms.Sickness and recovery of dogs challenged with a street rabies virus after vaccination with a vaccinia virus recombinant expressing rabies virus N proteinThe vaccination of man and other animals against rabies.Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence.Pathogenesis of street rabies virus infections in resistant and susceptible strains of mice.Comparison of human immune responses to purified Vero cell and human diploid cell rabies vaccines by using two different antibody titration methodsRabies virus inactivation by binary ethylenimine: new method for inactivated vaccine production.Evaluation of tests for rabies antibody and analysis of serum responses after administration of three different types of rabies vaccinesComparison of rabies humoral antibody titers in rabbits and humans by indirect radioimmunoassay, rapid-fluorescent-focus-inhibition technique, and indirect fluorescent-antibody assay.Rabies virus protein synthesis in infected BHK-21 cells.Oligosaccharides of the glycoprotein of rabies virus.Monoclonal antibodies against rabies virus produced by somatic cell hybridization: detection of antigenic variants.Immunogenicity study of glycoprotein-deficient rabies virus expressing simian/human immunodeficiency virus SHIV89.6P envelope in a rhesus macaqueThe protective antigens of equine herpesvirus type 1.Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV.Mutations conferring resistance to neutralization by a soluble form of the neurotrophin receptor (p75NTR) map outside of the known antigenic sites of the rabies virus glycoprotein.Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles.
P2860
Q24606451-9E2DAB87-8811-4A16-B4FB-CCEEC833FB1DQ24653467-8C48C452-FDE6-4640-AE94-8B2DAFE05C96Q27303650-A8C03D5E-576E-4964-A767-5B29E5E9ACD6Q27485054-32E11F97-0765-4AB6-B3D9-BD22A0CB6714Q28076429-656D8AF9-C4D0-4755-9677-7D4D108D3923Q31976725-1489DD5F-21E1-4EBE-B575-DCB2AAE268BBQ33620685-FBD8281B-ED58-4A43-A016-4D6E8F7A6DE1Q33639069-FFE99392-BC8F-421C-8990-19F3EEFC6EB0Q33670847-C368F3FB-85F9-4479-80FC-566602F1F790Q33838289-E4225DBE-D605-408E-86ED-DFD34F2CFE8AQ33845383-2168C649-E37B-45FE-9B03-5BB96A3AD8CBQ33867863-A3FD6476-79D5-4EB9-91BC-DAD7306FCC7CQ34106638-0439B412-92C5-4BC2-BDDD-421822C22F82Q34334103-7F8B78C2-C871-45A1-87BC-48C3839A5F94Q34408674-79EA9582-30E6-4CFA-A25F-A63DA89DAFA3Q35072506-77A4800C-E40D-4CC5-A74C-20815C0721B8Q35232003-50766729-9968-45D0-BFBB-02E5D3097349Q35608744-9BAEBCE9-4C51-46E1-9E6A-37C2923508C5Q35853085-5269D207-F4AB-4F65-868D-48148915D3A4Q36341057-AA970AB0-18F4-4E11-BF84-7404FCC2B4F2Q36552421-DF4E567C-45B5-4871-94F1-B633C6523D08Q36559952-BFAD564A-8521-43B1-9B7F-60DF8E9A7801Q36562738-64D3103A-46FD-4D27-83CF-A56B49062068Q36598941-2DEF15EB-2D86-48FC-8078-FFEED9B22ACBQ36696504-C0BA4862-F895-4B30-A31F-A7A7EA37F876Q36809968-2886F8F3-89FE-46A2-ADEA-71F135BC706AQ36825571-6910DDE9-922C-4F56-BDA7-3F51E34EB68DQ36904835-D47C5ECC-6306-4939-BA12-5808735B7C2AQ37188116-8C1FFC80-56D8-4797-8EBE-C13DA1BABEB0Q37322600-0E0A2392-67C6-4242-BF2C-ECB68F308523Q37350885-8E871B4B-96EA-417B-B132-0326E6337D29Q37351148-58AECC36-F9C7-4417-92E5-176228F64A78Q37504377-DE98E155-46ED-4BE1-8899-E5B190B909A0Q37506606-6CC96B9A-3D16-43C1-A77E-67CB9F6850A8Q37592947-CFD187B7-1ACA-41DB-AB60-C7424A6CC421Q37683291-3AB611E5-7641-49A5-849F-F04C64E12D3FQ39522934-FCEF53D6-54E4-4161-A492-74CB1CCC6A4DQ39633419-1057CF4C-C2FC-47A6-A6F0-3AEFD9E481B2Q39685255-10A285C1-4447-4F87-AB21-8308F283CC14Q39869015-67635EF5-B66F-433B-99F5-DD335F4FBF67
P2860
description
1973 nî lūn-bûn
@nan
1973 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1973 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
name
Antigenic properties of rabies virus components.
@ast
Antigenic properties of rabies virus components.
@en
Antigenic properties of rabies virus components.
@nl
type
label
Antigenic properties of rabies virus components.
@ast
Antigenic properties of rabies virus components.
@en
Antigenic properties of rabies virus components.
@nl
prefLabel
Antigenic properties of rabies virus components.
@ast
Antigenic properties of rabies virus components.
@en
Antigenic properties of rabies virus components.
@nl
P2093
P1476
Antigenic properties of rabies virus components.
@en
P2093
Koprowski H
Schlumberger D
P304
P407
P577
1973-01-01T00:00:00Z